Z
Zhuoyu Li
Researcher at Shanxi University
Publications - 157
Citations - 3749
Zhuoyu Li is an academic researcher from Shanxi University. The author has contributed to research in topics: PKM2 & Chemistry. The author has an hindex of 29, co-authored 126 publications receiving 2617 citations. Previous affiliations of Zhuoyu Li include Zhejiang Chinese Medical University & Chinese Ministry of Education.
Papers
More filters
Journal ArticleDOI
LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis
TL;DR: The results indicate that linc-ROR functions as an important regulator of EMT and can promote breast cancer progression and metastasis through regulation of miRNAs.
Journal ArticleDOI
Glucose regulated protein 78: A critical link between tumor microenvironment and cancer hallmarks
Zongwei Li,Zhuoyu Li +1 more
TL;DR: The potential contributions of GRP78 to the acquisition of cancer hallmarks based on intervening in stress responses caused by tumor niche alterations are reviewed.
Journal ArticleDOI
Pyruvate kinase M2 facilitates colon cancer cell migration via the modulation of STAT3 signalling.
TL;DR: This study suggests that PKM2 overexpression promotes CRC cell migration and cell adhesion by regulating STAT3-associated signalling and thatPKM2 may serve as a therapeutic target for CRC metastasis.
Journal ArticleDOI
The multifaceted regulation and functions of PKM2 in tumor progression.
TL;DR: The richness of the authors' understanding on the modulations and functions of PKM2 in tumor progression is reviewed, and some new insights into the paradoxical expression and functional differences of PKm2 in distinct cancer types are offered.
Journal ArticleDOI
MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway.
Tianpeng Zhang,Junjie Hu,Xiaomei Wang,Xiaoling Zhao,Zhuoyu Li,Junqi Niu,Clifford J. Steer,Guohua Zheng,Guisheng Song,Guisheng Song +9 more
TL;DR: MiR-378 plays a key role in the development of hepatic inflammation and fibrosis by positively regulating the NF-κB-TNFα axis and is a potential therapeutic target for the treatment of NASH.